[7] |
夏瑰林,贾敏.消疕汤对银屑病临床疗效及血清TGF-B 1、SOD变化的观察[D].贵阳:贵阳中医学院,2010,23-25.
|
[8] |
李薇薇.中医辨证联合甘草酸二胺和阿维A治疗泛发性脓疱型银屑病疗效观察[J].临床和实验医学杂志,2014,13(22):1879-1881.
|
[1] |
姚乃礼.中医证候鉴别诊断学[M].2版.北京:人民卫生出版社,2004.
|
[2] |
张学军.皮肤性病学[M].8版.北京:人民卫生出版社,2013.
|
[3] |
Marks R,Borton SP,Shutt1eworth D,et al.Assessment of disease progress in psoriasis[J].Arch Dermato1,1989,125 (2):235-240.
|
[4] |
Capon F,Burden AD,Trembath RC,et al.Psoriasis and other comp1ex trait dermatoses:from 1oci to functiona1 pathways[J].Invest Dermato1,201,132(3pt2):915-922.
|
[11] |
胡建红,姚学群,宋守荣,等.寻常型银屑病患者血清IL-17和IL-18水平的变化及相关性研究[J].贵州医药,2013,37(7):586-588.
|
[5] |
Chen H,Poon A,Yeung C,et al.Agenetic risk score combining tenpsoriasis risk 1oci improves disease prediction[J]. PLoS One,2011,6(4):e19454.
|
[6] |
Torres T,Bettencourt N,Ferreira J,et al.Inf1uence of TNF-α gene po1ymorphisms in coronary artery ca1cification in psoriasis patients[J].Eur Acad dermato1 Venereo1,2016,30 (1):191-193.
|
[9] |
任兴斌,诸葛宝忠,季海生.湿疹患者外周血CD4+CD25+FOXP3+调节性T细胞和血清IL-4,IL-10,TGF-β检测及临床研究[J].现代检验医学杂志,2010,25(3):131-133,136.
|
[10] |
Rasmy H,Mikhae1 N,Ismai1 S.Inter1eukin-18 expression and the response to treatment in patients with psoriasis[J]. Arch Med Sci,2011,7(4):713-719.
|
[12] |
Asadu11ah K,Friedrich M,Hanneken S,et al.Effects of systemic inter1eukin -10 therapy on psoriatic skin 1esions:histo1ogic immunohisto1ogic,and mo1ecu1ar bio1ogy findings[J].Invest Dermato1,2001,116(5):721-727.
|
[13] |
Carter NA,Rosser EC,Mauri C.Inter1eukin-10 produced by B ce11s is crucia1 for the suppression of Th17/Th1 responses,induction of T regu1atory type 1 ce11s and reductio of co11agen-induced arthritis[J].Arthritis Res Ther,2012,14(1):R32.
|
[14] |
汤雯剑,罗浩,赵金涛,等.银屑病患者血清中IL-10与IL-21水平监测的临床应用[J].现代检验医学杂志,2015,30(2):65-67.
|
[15] |
尹诗,黄莉,吴军,等.虫类药在中医药治疗银屑病中的应用[J].中医外治杂志,2014,23(5):59-60.
|
[16] |
王坤,刘爱民.中医扶阳疗法治白疕[J].中国中西医结合皮肤性病杂志,2010,9(1):38-39.
|